首页|参苓白术散调控TLR4/NLRP3通路对酒精性肝病治疗作用的机制研究

参苓白术散调控TLR4/NLRP3通路对酒精性肝病治疗作用的机制研究

扫码查看
该研究旨在探究参苓白术散(SBP)对酒精性肝病(ALD)细胞自噬的调控作用,以及其通过TLR4/NLRP3通路的干预效果。通过高度白酒灌胃法建立慢性酒精性肝病大鼠模型,并采用乙醇刺激BRL3A大鼠肝细胞建立ALD细胞模型;通过HPLC对SBP进行成分测定;对酒精性肝病大鼠肝组织进行苏木精-伊红(HE)染色和油红O染色,进行病理评估;采用ELISA检测脂多糖(LPS)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)和白细胞介素-18(IL-18)水平,利用qRT-PCR评估髓样分化因子88(MyD88)、Toll样受体4(TLR4)的mRNA表达;采用CCK-8分析不同药物对BRL3A细胞增殖活性的影响;通过Western blot分析核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)、核因子κB(NF-κB、P65)、磷酸化核因子(p-P65)、半胱氨酸蛋白酶1(caspase-1)、核孔糖蛋白(P62)、苄氯素1(Beclin1)和微管相关蛋白1轻链3(LC3 Ⅱ)蛋白表达。结果显示SBP能改善肝脏脂质沉积,降低肝功能,缓解肝脏组织炎症反应,降低LPS、TNF-α、IL-1β和IL-18;此外,SBP可以通过TLR4/NLRP3信号通路干预长期酒精摄入导致的肝脏过度自噬,并降低LC3 Ⅱ和Beclin1表达,升高P62的表达,并促进自噬溶酶体生成。该研究结果表明,参苓白术散可以显著改善慢性酒精性肝病的肝功能和血脂异常,通过抑制TLR4/NLRP3通路,调控长期高度白酒喂养引发的过度自噬反应。
Mechanism of Shenling Baizhu Powder on treatment of alcoholic liver disease by regulating TLR4/NLRP3 pathway
This study aims to investigate the regulatory effects of Shenling Baizhu Powder(SBP)on cellular autophagy in alcoholic liver disease(ALD)and its intervention effect through the TLR4/NLRP3 pathway.A rat model of chronic ALD was established by gavage of spirits.An ALD cell model was established by stimulating BRL3A cells with alcohol.High-performance liquid chromatography(HPLC)was utilized for the compositional analysis of SBP.Liver tissue from ALD rats underwent hematoxylin-eosin(HE)and oil red O staining for pathological evaluation.Enzyme-linked immunosorbent assay(ELISA)was applied to quantify lipopolysaccharides(LPS),tumor necrosis factor-alpha(TNF-α),interleukin-1 beta(IL-1β),and interleukin-18(IL-18)levels.Quantitative reverse transcription polymerase chain reaction(qRT-PCR)was conducted to evaluate the mRNA expression of myeloid differentiation factor 88(MyD88)and Toll-like receptor 4(TLR4).The effect of different drugs on BRL3A cell proliferation activity was assessed through CCK-8 analysis.Western blot analysis was performed to examine the protein expression of NOD-like receptor pyrin domain-containing 3(NLRP3),nuclear factor-kappa B P65(NF-κB P65),phosphorylated nuclear factor-kappa B P65(p-P65),caspase-1,P62,Beclinl,and microtubule-associated protein 1 light chain 3(LC3 Ⅱ).The results showed that SBP effectively ameliorated hepatic lipid accumulation,reduced liver function,mitigated hepatic tissue inflammation,and reduced levels of LPS,TNF-α,IL-1β,and IL-18.Moreover,SBP exhibited the capacity to modulate hepatic autophagy induced by prolonged alcohol intake through the TLR4/NLRP3 signaling pathway.This modulation resulted in decreased expression of LC3 Ⅱ and Beclin1,an elevation in P62 expression,and the promotion of autolysosome formation.These research findings imply that SBP can substantially enhance liver function and mitigate lipid irregularities in the context of chronic ALD.It achieves this by regulating excessive autophagic responses caused by prolonged spirit consumption,primarily through the inhibition of the TLR4/NLRP3 pathway.

alcoholic liver diseaseautophagyShenling Baizhu PowderTLR4/NLRP3 pathway

蔡世揿、周素芳、周丽芳、李玉茹、周相宇、吕方怡

展开 >

贵州中医药大学第一附属医院,贵州贵阳 550000

贵州中医药大学第一附属医院消化内科,贵州贵阳 550000

酒精性肝病 自噬 参苓白术散 TLR4/NLRP3通路

国家自然科学基金贵州省科技计划

81460683黔科合支撑[2021]—般015

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(5)
  • 1
  • 48